{"entity":{"id":"aldevron","kind":"company","name":"Aldevron (Danaher)","aka":[],"tldr":"Leading GMP plasmid DNA and mRNA raw-material supplier, acquired by Danaher for $9.6B in 2021.","summary":"Aldevron, based in Fargo, North Dakota, and acquired by Danaher for 9.6 billion dollars in 2021, is the leading GMP supplier of plasmid DNA and mRNA raw materials. It makes plasmid DNA, mRNA and proteins including Cas9 for gene, cell and mRNA therapies, and it supplied the templates for COVID mRNA vaccines. OnCo links it to plasmid DNA and mRNA raw-material manufacturing, the starting point for viral vectors, CAR-T cells and mRNA cancer vaccines alike. Whether raw-material supply keeps pace as personalised mRNA vaccines and in vivo CAR-T move towards approval is the open question for a company at the bottom of the supply chain. The raw-material manufacturing page carries the wider picture.","asOf":"2026-09-08","links":[{"label":"Official website","url":"https://www.aldevron.com"}],"tags":["supporting"],"related":[],"cancers":[],"sections":["cell-therapy","immunotherapy"],"technologies":["plasmid-dna-manufacturing"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Fargo, ND","country":"US","companyType":"cro-services","website":"https://www.aldevron.com","investors":[],"funding":[]},"route":"/companies/aldevron/","neighbours":{"section":[{"id":"cell-therapy","kind":"section","name":"Cell Therapy","route":"/fronts/cell-therapy/"},{"id":"immunotherapy","kind":"section","name":"Immunotherapy","route":"/fronts/immunotherapy/"}],"technology":[{"id":"mrna-lnp-manufacturing","kind":"technology","name":"mRNA and lipid nanoparticle manufacturing","route":"/technologies/mrna-lnp-manufacturing/"},{"id":"plasmid-dna-manufacturing","kind":"technology","name":"Plasmid DNA and mRNA raw-material manufacturing","route":"/technologies/plasmid-dna-manufacturing/"}]}}